Skip to content
★ Sign in to follow
RD

Robert Dickey IV

CFO
Vyome Holdings, IncAIM ImmunoTech Inc.Lisata Therapeutics, Inc.
Total declarations
6
Companies
3
▲ Purchases (1 ops.)
€1,089
▼ Sales (0 ops.)
—

Latest filing published 11 Sept 2025 for Vyome Holdings, Inc.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 08 Dec 2009 · 6179 days ago · €1,089
    -16.9%
    Entry US$30,215.32 · Close at T+365 US$25,094.08

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert Dickey IV: trading record in brief

Robert Dickey IV has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lisata Therapeutics, Inc., AIM ImmunoTech Inc. and Vyome Holdings, Inc. Between 8 December 2009 and 15 August 2025, the trades on record add up to 6 filings.

The open-market record is one-sided, with 1 purchase worth €1,089 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 5 share grants.

On 11 September 2025 came the latest disclosure, a share grant in Vyome Holdings, Inc. The most recent open-market purchase was published on 8 December 2009, 6,179 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Robert Dickey IV

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total

6 of 6 declarations